![Frank L. Porfido](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Perfil
Frank L.
Porfido held the position of Chief Financial Officer at Tyme Technologies, Inc. in 2021 and Vice President-Finance at UroGen Pharma, Inc. from 2019 to 2021.
He earned an MBA from Fairleigh Dickinson University and an undergraduate degree from Pace University.
Antiguos cargos conocidos de Frank L. Porfido.
| Empresas | Cargo | Fin |
|---|---|---|
| TYME TECHNOLOGIES, INC. | Director Financiero/CFO | 16/09/2022 |
UroGen Pharma, Inc.
 UroGen Pharma, Inc. BiotechnologyHealth Technology Operates as a biotech company that developing and commercializing innovative solutions to treat urothelial and specialty cancers | Corporate Officer/Principal | 01/05/2021 |
Formación de Frank L. Porfido.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
11
Relaciones de 1er grado
4
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 4 |
|---|---|
Tyme Technologies, Inc.
 Tyme Technologies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops cancer metabolism-based therapeutics | Health Technology |
Fairleigh Dickinson University
 Fairleigh Dickinson University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pace University
 Pace University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
UroGen Pharma, Inc.
UroGen Pharma, Inc. BiotechnologyHealth Technology Operates as a biotech company that developing and commercializing innovative solutions to treat urothelial and specialty cancers | Health Technology |
- Bolsa de valores
- Insiders
- Frank L. Porfido
